A recent study identified G-protein-coupled receptor 34 (GPR34) as a key immune checkpoint receptor on ILC1s that senses lysophosphatidylserine (LysoPS), a lipid enriched in the TME, primarily derived from tumor cells and infiltrating apoptotic immune cells. This evidence concerns the gene GPR34 and neoplasm.